| 52.97 Data as of May 24 | +0.24 / +0.46%Today’s Change | 41.68 Today|||52-Week Range 53.45 | +21.85% Year-to-Date |
| Elan Rejects Royalty Offer Again - Analyst Blog May 24 / Zacks.com | XenoPort Candidate Disappoints - Analyst Blog May 21 / Zacks.com |
| Want to invest in Samsung? Good luck! May 24 / CNNMoney.com | Elan Provides Strategic Update - Analyst Blog May 21 / Zacks.com |
| Impax Launches Generic Zomig - Analyst Blog May 23 / Zacks.com | GlaxoSmithKline Stock Hits New 52-Week High (GSK) May 21 / TheStreet.com |
| Data on UCB's Neupro - Analyst Blog May 22 / Zacks.com | Dirty Medicine May 15 / Fortune |
| XenoPort Resumes Horizant Supply - Analyst Blog May 22 / Zacks.com | Wider-than-Expected Loss at ChemoCentryx - Analyst Blog May 14 / Zacks.com |
| Toll Reports Better-than-Expected Earnings: Ahead of the Ticker May 22 / TheStreet.com | Glaxo/THRX's Breo Ellipta Gets FDA Nod - Analyst Blog May 13 / Zacks.com |